IGMS - IGM Biosciences plans for $100M stock offering and concurrent private placement
2023-06-21 17:35:02 ET
-
IGM Biosciences ( NASDAQ: IGMS ) said Wednesday that it intends to offer and sell $100 million of its common stock in an underwritten public offering.
-
Underwriters have a 30-day option to purchase up to an additional 15% of the shares being offered.
-
All of the securities offered in the proposed public offering will be sold by IGM.
-
The pricing details of the offering were not disclosed.
-
IGM also intends to sell shares of non-voting common stock to certain institutional investors in a concurrent private placement.
-
BofA Securities, Jefferies, Stifel, and Guggenheim Securities are acting as joint book-running managers for the proposed public offering.
For further details see:
IGM Biosciences plans for $100M stock offering and concurrent private placement